Sierra Oncology Company Profile, Contacts & Intelligence
Sierra Oncology Overview
Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. We harness our deep scientific expertise to identify compounds that target the root cause of disease to advance targeted therapies with assets on the leading edge of cancer biology. Our team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Together we are transforming promise into patient impact. Our lead product candidate, momelotinib, is a selective and orally bioavailable JAK1, JAK2 and ACVR1 inhibitor currently under investigation for the treatment of myelofibrosis. Myelofibrosis results from dysregulated JAK-STAT signaling and is characterized by constitutional symptoms, splenomegaly (enlarged spleen) and progressive anemia. Momelotinib is currently under investigation in the MOMENTUM clinical trial, a global, randomized, double-blind Phase 3 study for symptomatic and anemic myelofibrosis patients. Top-line data are anticipated in H1 2022. The U.S. Food & Drug Administration has granted Fast Track designation for momelotinib. Our pipeline also consists of SRA737, a potent, highly selective, orally bioavailable small molecule inhibitor of Checkpoint kinase 1 (Chk1). Promising clinical activity has been observed with SRA737 in combination with low-dose gemcitabine (LDG). Additionally, SRA737 and LDG strongly synergizes with anti-PD(L)1 preclinically, enabling further promising clinical development opportunities. For more information, please visit www.SierraOncology.com.
- Headquarters
- San Mateo, California, United States
- Website
- sierraoncology.com
- Industry
- Biotechnology Research
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
- Phone Number
- Available in AeroLeads
- Company Email
- Available in AeroLeads
Sierra Oncology Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Sierra Oncology People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Sierra Oncology Workforce Composition
Seniority breakdown across 4 visible profiles.
Compare Similar Companies to Sierra Oncology
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Pfizer | Pharmaceutical Manufacturing | 100.69K | View company |
| GSK | Pharmaceutical Manufacturing | 90.45K | View company |
| Sanofi | Pharmaceutical Manufacturing | 88.33K | View company |
| ViiV Healthcare | Pharmaceutical Manufacturing | 1.88K | View company |
| TESARO, Inc. | Pharmaceutical Manufacturing | 55 | View company |
| Bellus Health | Biotechnology Research | 20 | View company |
| Elsie Biotechnologies | Biotechnology Research | 18 | View company |
| Affinivax Inc. | Biotechnology Research | 16 | View company |
| Aiolos Bio | Biotechnology Research | 3 | View company |
| CELLphenomics GmbH | Biotechnology | Not listed | View company |